Jones Financial Companies’s iRadimed IRMD Stock Holding History

Jones Financial Companies’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.3K	Sell	706 -17	-2%	-$1.55K	﹤0.01%	3003
2026 Q1	$70.4K	Sell	723 -90	-11%	-$9K	﹤0.01%	2816
2025 Q4	$79.1K	Sell	813 -30	-4%	-$2.57K	﹤0.01%	2305
2025 Q3	$59.2K	Sell	843 -50	-6%	-$3.33K	﹤0.01%	2300
2025 Q2	$54.3K	Buy	893 +44	+5%	+$2.41K	﹤0.01%	2195
2025 Q1	$44.5K	Buy	849 +719	+553%	+$40.4K	﹤0.01%	2110
2024 Q4	$7.15K	Buy	+130	New	+$6.84K	﹤0.01%	2650

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jones Financial Companies's IRMD Position: Q2 2026 in Review

Jones Financial Companies reduced its iRadimed (IRMD) stake by 2.4% in Q2 2026, selling an estimated $1.55K and leaving 706 shares worth $66.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Jones Financial Companies first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $79.1K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Jones Financial Companies held 706 shares of iRadimed worth $66.3K as of Q2 2026.
Jones Financial Companies sold 17 iRadimed shares in Q2 2026, an estimated $1.55K.
iRadimed made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3003 holding.
Jones Financial Companies first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
Jones Financial Companies's iRadimed position peaked at $79.1K in Q4 2025.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.